Anbio Biotechnology Class A (NNNN) Stock Statistics & Valuation Metrics
Total Valuation
Anbio Biotechnology Class A has a market cap or net worth of $559.74M. The enterprise value is $688.35T.
- Market Cap
- $559.74M
- Enterprise Value
- $688.35T
Share Statistics
Anbio Biotechnology Class A has 43,891,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 43,891,200
- Owned by Insiders
- ―
- Owned by Institutions
- 0.11%
Financial Efficiency
Anbio Biotechnology Class A’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 19.13%.
- Return on Equity (ROE)
- 0.21
- Return on Assets (ROA)
- 0.21
- Return on Invested Capital (ROIC)
- 19.13%
- Return on Capital Employed (ROCE)
- 0.19
- Revenue Per Employee
- 320.25K
- Profits Per Employee
- 237.17K
- Employee Count
- 27
- Asset Turnover
- 0.29
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Anbio Biotechnology Class A is 21.10. Anbio Biotechnology Class A’s PEG ratio is 0.21.
- PE Ratio
- 21.10
- PS Ratio
- 15.21
- PB Ratio
- 5.94
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- 0.21
Income Statement
In the last 12 months, Anbio Biotechnology Class A had revenue of 8.65M and earned 6.40M in profits. Earnings per share was 0.16.
- Revenue
- 8.65M
- Gross Profit
- 7.54M
- Operating Income
- 5.77M
- Pretax Income
- 6.40M
- Net Income
- 6.40M
- EBITDA
- 5.77M
- Earnings Per Share (EPS)
- 0.16
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Anbio Biotechnology Class A pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 4.81%
Stock Price Statistics
- Beta
- 1.58
- 52-Week Price Change
- -76.22%
- 50-Day Moving Average
- 5.05
- 200-Day Moving Average
- 16.50
- Relative Strength Index (RSI)
- 43.51
- Average Volume (3m)
- 151.38K
Financial Position
Anbio Biotechnology Class A as a current ratio of 344.31, with Debt / Equity ratio of 0.00%
- Current Ratio
- 344.31
- Quick Ratio
- 344.31
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -1.35
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Anbio Biotechnology Class A has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Anbio Biotechnology Class A EV to EBITDA ratio is 26.04, with an EV/FCF ratio of 0.00.
- EV to Sales
- 14.32
- EV to EBITDA
- 26.04
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Anbio Biotechnology Class A has $11.90M in cash and marketable securities with $0.00 in debt, giving a net cash position of $11.90M billion.
- Cash & Marketable Securities
- $11.90M
- Total Debt
- $0.00
- Net Cash
- $11.90M
- Net Cash Per Share
- $0.27
- Tangible Book Value Per Share
- $0.69
Margins
Gross margin is 86.10%, with operating margin of 65.20%, and net profit margin of 72.09%.
- Gross Margin
- 86.10%
- Operating Margin
- 65.20%
- Pretax Margin
- 72.09%
- Net Profit Margin
- 72.09%
- EBITDA Margin
- 55.00%
- EBIT Margin
- 65.20%
Analyst Forecast
The average price target for Anbio Biotechnology Class A is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 10.10%
- EPS Growth Forecast
- 170.13%
Scores
- Smart Score
- 2
- AI Score
- ―
